Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

Abstract Title:

High prevalence of breast cancer in patients with benign thyroid diseases.

Abstract Source:

J Endocrinol Invest. 2010 Jul 1. Epub 2010 Jul 1. PMID: 20595798

Abstract Author(s):

I Muller, A Pinchera, E Fiore, V Belardi, V Rosellini, E Giustarini, C Giani

Article Affiliation:

Department of Endocrinology, University of Pisa, Pisa, Italy. ilaria.muller@hotmail.it.

Abstract:

Background: in patients with breast cancer (BC) a high prevalence of benign thyroid diseases (BTD) has been described, Hashimoto's thyroiditis accounting for a large extent for this association. The aim of this study was to evaluate the prevalence of BC in a large group of patients with BTD. Patients: clinical records of 622 consecutive patients with BTD were examined. BC prevalence in BTD patients was compared with BC frequency in general population living in the same country. Results: BC prevalence in patients with BTD (38/622;6.11%) was significantly higher (p=0.0002) with respect to BC frequency in general population (2.07%). When patients were divided according to the age of menopause, in females older than 49 years BC frequency in BTD was significantly higher than in age-matched population (7.6% vs 3.3%; p= 0.006), while in female aged 30-49 years BC frequency in BTD was higher but not statistically significant than in age-matched population (3.7% vs 0.5%; p= 0.06). No significant difference of BC prevalence was found when patients were grouped according to the diagnosis of thyroid disorders: Graves' Disease, Hashimoto's Thyroiditis, Nodular Goiter associated or not associated with serum thyroid autoantibodies (TAb). No significant difference of BC frequency was observed between TAb+ (26/377;6.9%) and TAb- (12/245;4.9%) patients. The distribution of known risk factors for breast malignancies was similar in patients with or without BC. Conclusion: in patients with BTD the prevalence of BC is significantly higher than the expected, showing the usefulness of screening for breast malignancy of patients with BTD.

Study Type : Human Study

Print Options


Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2019 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.